InvestorsHub Logo
Followers 12
Posts 1150
Boards Moderated 0
Alias Born 10/17/2010

Re: jessellivermore post# 876

Saturday, 04/02/2011 4:43:58 PM

Saturday, April 02, 2011 4:43:58 PM

Post# of 426467
In jelis study epa showed survival but in the patient who already had history of CAD but it did improved to one who did not had CAD.. which i think is very difficult to prove. In out come study i think AMRN will go for people who already had history of CAD and if FDA agrees that would be huge. correct me if i am wrong.

And remember in marine trial epa did showed stastical significant reduction in APO -B and NON HDL C which by it self are considered major risk factor and if same holds true with anchor that will be great for AMRN.

Any thoughts?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News